iBio
IBIO
#9842
Rank
NZ$77.32 M
Marketcap
NZ$3.44
Share price
5.32%
Change (1 day)
-21.64%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$2.63

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$2.67. In 2024 the company made an earnings per share (EPS) of NZ-$11.29 an increase over its 2023 EPS that were of NZ-$184.42.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$2.63-76.7%
2024NZ-$11.29-93.88%
2023NZ-$184.42-8.14%
2022NZ-$200.7692.67%
2021NZ-$104.20-80.33%
2020NZ-$529.69-35.11%
2019NZ-$816.25-38.96%
2018NZ-$1,337-6.1%
2017NZ-$1,42436.67%
2016NZ-$1,04233.33%
2015NZ-$781.5250%
2014NZ-$521.01-53.85%
2013NZ-$1,129-7.14%
2012NZ-$1,216-64.1%
2011NZ-$3,38777.27%
2010NZ-$1,910144.44%
2009NZ-$781.5212.93%
2008NZ-$692.0512.2%
2007NZ-$616.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Genocea Biosciences
GNCA
NZ-$0.90-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.45-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.13-777.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$13.84 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA